🎉 Finosauras is now Saras
Accretion Pharmaceuticals Ltd. logo

Accretion Pharmaceuticals Ltd. - Share Price Target 2026

(NSE: ACCPL)

Market Cap: 63.58 Cr

0.00

0.00 (0.00%)

CMP

Neutral

As on 13 Nov 2025, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish0
Bearish0
Neutral0
Agg. Profit Potential0.00%
Agg. Risk 0.00%

Last updated on: 13/11/2025, 3:30 pm

Fundamental Data

Fundamental Analysis

P/E Ratio

9.36

P/B Ratio

1.41

PEG Ratio

0.00

ROE

65.39%

EPS

6.11

Dividend Yield

N/A

Market Cap

63.58 Cr

Sector

N/A

Last Updated: 10 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Accretion Pharmaceuticals Ltd.

Incorporated Year

City and State

Listing Date

Director's Name

Revenue

5737.62 Cr

Net Profit

976.38 Cr